Projects

prof. MUDr. Michal Mego, DrSc.

International

Current
  • Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer
    Program: ERANET
    Duration: 1. 9. 2024 – 31. 8. 2027

National

Finished
  • Identification of potential therapeutic targets associated with cisplatin resistance in yolk sac tumors
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Molecular biomarkers of relapse in seminoma clinical stage I patients
    Program: Other projects
    Duration: 1. 10. 2019 – 21. 12. 2022
  • Turning cisplatin-resistant testiular germ cell tumors into a curable disease
    Program: SRDA
    Duration: 1. 8. 2018 – 31. 12. 2021
Employees